Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) fell 23.3% during trading on Friday . The company traded as low as C$0.12 and last traded at C$0.12. 1,797,794 shares were traded during trading, an increase of 540% from the average session volume of 280,948 shares. The stock had previously closed at C$0.15.
VentriPoint Diagnostics Trading Down 23.3 %
The company has a market capitalization of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The business has a fifty day moving average price of C$0.10 and a 200 day moving average price of C$0.13. The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- Investing in Commodities: What Are They? How to Invest in Them
- Realty Income: An Anchor in Volatile Markets
- ESG Stocks, What Investors Should Know
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Are Penny Stocks a Good Fit for Your Portfolio?
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
